MERCK Kommanditgesellschaft auf Aktien (0O14) - Total Liabilities
Based on the latest financial reports, MERCK Kommanditgesellschaft auf Aktien (0O14) has total liabilities worth €21.93 Billion EUR as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MERCK Kommanditgesellschaft auf Aktien - Total Liabilities Trend (2020–2024)
This chart illustrates how MERCK Kommanditgesellschaft auf Aktien's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MERCK Kommanditgesellschaft auf Aktien Competitors by Total Liabilities
The table below lists competitors of MERCK Kommanditgesellschaft auf Aktien ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gold Circuit Electronics Ltd
TW:2368
|
Taiwan | NT$34.57 Billion |
|
TELUS
F:BCZ
|
Germany | €43.03 Billion |
|
OMV Aktiengesellschaft
VI:OMV
|
Austria | €23.77 Billion |
|
Telkom Indonesia (Persero) Tbk PT
JK:TLKM
|
Indonesia | Rp136.88 Trillion |
|
Merck KGaA
XETRA:MRK
|
Germany | €21.93 Billion |
|
JD HEALTH INTL LTD
F:8ZN
|
Germany | €20.48 Billion |
|
Divi's Laboratories Limited
NSE:DIVISLAB
|
India | Rs27.38 Billion |
|
Publicis Groupe SA
PA:PUB
|
France | €29.59 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down MERCK Kommanditgesellschaft auf Aktien's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MERCK Kommanditgesellschaft auf Aktien's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MERCK Kommanditgesellschaft auf Aktien (2020–2024)
The table below shows the annual total liabilities of MERCK Kommanditgesellschaft auf Aktien from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €21.58 Billion | -0.74% |
| 2023-12-31 | €21.74 Billion | -3.51% |
| 2022-12-31 | €22.53 Billion | -5.91% |
| 2021-12-31 | €23.95 Billion | -3.36% |
| 2020-12-31 | €24.78 Billion | -- |
About MERCK Kommanditgesellschaft auf Aktien
Merck KGaA operates as a science and technology company in Germany. The company's Life Science segment offers a range of products, including reagents, consumable, devices, instruments, software, and services for scientific discovery, as well as provides lab water instruments, consumables and services, microbiology and biomonitoring, products, test assays, analytical reagents, and flow cytometry k… Read more